12/17/2024 / By News Editors
Lawmakers Must Reject Big Pharma’s “Delinking” Scheme Designed to Boost Profits at the Expense of Seniors, Taxpayers and Employers
The Left is carrying Big Pharma’s water this lame duck by trying to cram in a disastrous money grab from America’s seniors that would boost drug company profits, and sever market-based incentives in the prescription drug marketplace.
(Article republished from ConservativesForLowerCaseCosts.com)
Conservatives from across the nation have rightly sounded the alarm:
See what more conservatives had to say about the Big Pharma “delinking” scheme HERE.
If implemented, this big government “delinking” mandate would directly intervene in the market to tip the scales in favor of Big Pharma, boosting their profits, and helping politicians on the Left move the country further to a fully government-controlled socialist health care system.
Casey Mulligan, Ph.D., former chief economist for the Council of Economic Advisers in the Trump Administration, concluded this policy would result in health care premium hikes of $13 billion for seniors. He also found federal spending would skyrocket by $10 billion every year.
Meanwhile, Big Pharma would get a $10 billion bailout in the form of higher profits each year.
Republicans MUST oppose this massive money grab from America’s seniors and taxpayers and REJECT the Big Government-Big Pharma “delinking” scheme.
Learn how pharma originated the idea of “delinking” HERE.
Read more at: ConservativesForLowerCaseCosts.com
Tagged Under:
big government, Big Pharma, cancel Democrats, conspiracy, corruption, deception, Delinking, finance, finance riot, government, left, market, money grab, money supply, pharma fraud, scheme, Vote Republican
This article may contain statements that reflect the opinion of the author
PrescriptionWarning.com is a fact-based public education website published by Prescription Warning Features, LLC.
All content copyright © 2018 by Prescription Warning Features, LLC.
Contact Us with Tips or Corrections
All trademarks, registered trademarks and servicemarks mentioned on this site are the property of their respective owners.